Effective management of chronic conditions such as diabetes is increasingly important in occupational health. At Nuvo Health, our HBG A1C Testing (Hemoglobin A1C) measures average blood glucose levels over the prior 2–3 months, allowing early detection of prediabetes or diabetes in your workforce. This test is a powerful tool for health monitoring, wellness programs, and risk mitigation.
During testing, we draw a small blood sample and use laboratory methods to quantify the percentage of glycated hemoglobin (A1C). Because the test reflects long-term glucose control rather than a single point in time, it is more stable and predictive than random glucose measures. Based on results, we categorize glycemic control (e.g., normal, prediabetes, diabetic) per ADA guidelines.
If results indicate elevated A1C values, we provide interpretation and guidance: referral to primary care, nutritional counseling, lifestyle interventions, or further metabolic testing. We partner with employees and your wellness initiatives to support behavior change, monitoring, and follow-up. This makes A1C testing not just diagnostic but preventive.
We maintain confidential health records and provide aggregate analytics (de-identified) if you wish to monitor population health trends. That way, you can assess program effectiveness, target at-risk groups, and allocate wellness resources wisely. The test is efficient, minimally invasive, and cost-effective for routine screening.
Employers may include HBG A1C as part of an annual health battery or wellness screening panel. Because diabetes risks impact workforce health, productivity, and healthcare costs, regular A1C screening is a valuable addition to your occupational health suite. Contact Nuvo Health to include A1C testing in your health monitoring programs.